Liu et al. reported that YZT, a novel PDK1/MEK dual inhibitor, induces protective autophagy in non-small cell lung cancer cells through the PDK1/Akt signaling pathway (Liu R. et al., 2023). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.